ALNY vs UFPT · P/E 76, rev $1.29B vs P/E 26, rev $148.9M
Alnylam Pharmaceuticals Inc (ALNY) versus UFP Technologies Inc (UFPT) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
UFP Technologies Inc (UFPT) is a medical devices company listed on NASDAQ.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported UFPT revenue for 2025-12-31 was $148.9M. Net income was $17.6M. Revenue was down 1.5% from 2025-06-30 to 2025-12-31. UFPT currently screens at market cap $1.76B and trailing P/E 26.0.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. UFPT currently screens at market cap $1.76B and trailing P/E 26.0.
Not investment advice. Open the ALNY and UFPT stock pages for the full models.
Not investment advice.